搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
搜索
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 7 天
时间不限
过去 1 小时
过去 24 小时
过去 30 天
按时间排序
按相关度排序
6 小时
Coinbase: Market Underestimating A Blockbuster Quarter
For Q4 2024 earnings, Coinbase is expected to beat Wall Street revenue estimates by 26% and EPS estimates by 407%. See why I ...
Ever-Growing USA on MSN
1 天
Blue Salt Trick: The Male Enhancement Formula Redefining Vitality and Confidence
In today's world, many men are seeking effective solutions to enhance their performance and regain confidence. Whether it's ...
1 天
Roche Q4 Earnings Review: Solid All-Court Performance, But Quiet On GLP-1 Progress
Roche Holding AG delivered a strong set of 2024 earnings. Guidance for 2025 suggests this will be a transitional year ahead, ...
2 天
Somehow, some way, Edge has over 30% market share in the US on Windows—and has taken ...
Nadella further detailed the growth, sharing, "Search and News advertising revenue ex-TAC increased 21% and 20% in constant ...
4 天
on MSN
Seeking Alpha Review: Best Investment Websites to Research Stocks
We recently published a list of the 12 Best Investment Websites To Research Stocks. In this article, we will look at where ...
Pharmabiz
5 天
US FDA grants priority review status to Merck’s sNDA for Welireg to treat patients with ...
Rahway, New Jersey Tuesday, January 28, 2025, 10:00 Hrs [IST] ...
Contract Pharma
5 天
Merck’s WELIREG Accepted for Priority Review by FDA for Pheochromocytoma and Paraganglioma
The supplemental new drug application is based on data from the Phase 2 LITESPARK-015 trial.
6 天
Merck: FDA grants priority review to sNDA for Welireg
Merck (MRK) announced the U.S. FDA has accepted for priority review a supplemental new drug application seeking approval of Welireg, Merck’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈